Li Yuexia sort out

[email protected]

Rich countries and developing countries may reach an agreement on the issue of exemptional vaccine intellectuals within a few weeks.

The vaccination rate of developing countries has always lagged behind the rich country. One of the main reasons is that the vaccine supply is unbalanced.According to the International Monetary Fund, as of December 31, 2021, the vaccination rate of coronary vaccines in 86 countries around the world was less than 40%.

India and South Africa submitted motion to the World Trade Organization in October 2020, asking for the suspension of intellectual property protection of crown -related medical equipment such as vaccines so that more countries can produce vaccines.Subsequently, manufacturers in India, Bangladesh, Canada, Denmark and other places also said that they have the ability to produce vaccines, and what is missing is only production permits.The position of objepering anti -vaccine intellectual rights is to combat innovation and further exacerbate the shortage of vaccine raw materials.

The United States Biden Government turned unexpectedly to support patent exemption in early May last year, which put pressure on the opposition countries such as the European Union and Switzerland.

The Director -General of the WTO Outon -Ivera said on Friday on the issue of exempting the vaccine patent on Friday: "We hope there will be a breakthrough in the next few weeks ... ... There may be a wise compromiseSolutions allow developing countries to obtain more technical transfer and intellectual property rights, but also protect innovation and research. "

But she said that the parties may not be unable to be on February 17, the European Union -African Union on February 17The summit reached an agreement before the opening of Brussels.

The French Minister of Foreign Trade List also said at a press conference: "Intellectual property rights must not be a brake in developing countries (obtaining vaccines)." France took over the EU rotation chairman this month.

At the same time, the British scientific community calls on the Johnson government to support intellectual property rights to abandon vaccine, testing and therapeutic products.

About 300 scientists are required to support the government to support the government to support the British Minister of Health, Trade, Business, and Foreign Minister.Crown disease vaccine patent rights to increase vaccine output.

They also urged the government to persuade the pharmacy company to share this technology and knowledge with the World Health Organization.

The WTO has been promoted a series of meetings since the end of June 2021 to discuss some scope of the revocation of the coverage of intellectual property agreement; however, the WTO has no right to sharing vaccine technology.

According to Bloomberg's previous report, intellectual property lawyers believe that if an agreement is reached within the framework of the WTO and abandoned the protection of vaccine patents and commercial secrets, the American pharmaceutical dealers may ask the government for compensation.